-
-
Call more information
660-596-2224 -
Authors: Rice ASC et al., Lancet 2014 May 10; 383:1637 A phase 2 trial demonstrates the potential of angiotensin II type 2 antagonists, a new treatment target, to relieve the chronic neuropathic pain of postherpetic neuralgia. Because existing treatments for postherpetic neuralgia are often insufficient or ineffective, researchers have been investigating EMA401, an oral angiotensin […]
Read MoreIf a patient doesn’t pay his health insurance premiums, the insurer doesn’t have to pay the provider for care rendered during the grace period. That means that up to two months of provider services may not be reimbursed. A little-known provision in the Patient Protection and Affordable Care Act could leave physicians holding the bag […]
Read MoreAuthors: Weiss E et al., Br J Anaesth 2014 Jul 113:52 A new finger-cuff device might be useful as an early warning system for hemodynamic variability, but it is not a replacement for invasive monitoring. The Nexfin is a noninvasive finger-cuff device that uses photoplethysmographic technology to continuously measure arterial pressure. To compare Nexfin measurements […]
Read MoreThe Obama administration announced Wednesday that a new anti-fraud program in Medicare doubled the improper payments it identified or prevented this year. The Fraud Prevention System at the Centers for Medicare and Medicaid Services (CMS) recovered or prevented more than $210 million of improper payments in its second year, the agency told Congress in a […]
Read MoreRalph Wuebker, MD, chief medical officer for Executive Health Resources, shared three myths on Medicare audits during a presentation at the Healthcare Financial Management Association’s Annual National Institute in Las Vegas earlier this week. Myth #1: There’s no audits right now. In January, the Office of Medicare Hearings and Appeals suspended the assignment of audit […]
Read More